Qelbree is proven to significantly reduce ADHD symptoms in 3 clinical trials
In clinical studies, Qelbree—a non-stimulant—was proven to help effectively manage ADHD symptoms.
Rapid and extended release for full-day coverage.
By reducing the impact of ADHD symptoms, Qelbree can help improve your child's difficult behavior related to ADHD. Qelbree met the goal of 3 different clinical trials – a significant reduction in ADHD symptom scores in 6 weeks. For some patients, Qelbree reduced ADHD symptom scores as early as week 1.
Your child’s doctor can recommend Qelbree as part of a total treatment program that may include counseling and support therapies.
Clinical Trial Results
How we ran the studies:
Qelbree was studied in three clinical trials involving boys and girls ages 6-17 who had been diagnosed with ADHD.
The studies measured what kind of changes in ADHD symptoms these children experienced over the course of the six- to eight-week clinical trials. They measured the frequency and severity of ADHD symptoms, including inattention, hyperactivity, and impulsivity.
Qelbree showed significant reduction in symptoms compared to placebo.
Qelbree was also consistently proven to be effective and safe in multiple clinical studies in over 800 patients with a once-a-day convenient dose.
A school routine that’s
Qelbree is proven to be safe*, with manageable side effects
In clinical trials, Qelbree was consistently proven to be a safe and effective treatment for ADHD, with a low incidence of side effects.
*Important: Monitor your child for mood or behavior changes. Your child’s doctor may also monitor for changes in blood pressure and heart rate.
The majority of these side effects did not cause children to stop treatment with Qelbree.
Qelbree is not a controlled substance and there was no evidence of abuse.
Sometimes parents consider a planned break or "drug holiday" from a medication due to side effects. This is a conversation you should have with your child and with their doctor before considering a break.
Qelbree is unlikely to have any negative interactions with stimulants like methylphenidate and amphetamine.
Most Common Side Effects
‡Somnolence: somnolence, lethargy, sedation
§Trouble sleeping: initial insomnia, insomnia, middle insomnia, poor quality sleep, sleep disorder, terminal insomnia.
Only 3% of participants taking Qelbree discontinued the clinical trial due to side effects, while 1% of those taking the placebo discontinued the clinical trial.